PubRank
Search
About
Bruno Jawan
Author PubWeight™ 56.52
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy.
Anesthesiology
2006
3.09
2
Difficult ventilation with a double-lumen endotracheal tube: an unusual manufacturing defect.
Anesth Analg
2005
2.14
3
Living donor liver transplantation: the Asian perspective.
Transplantation
2014
2.13
4
Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
J Hepatol
2010
1.67
5
Massive pulmonary embolism presented as sudden cardiac arrest in the immediate postoperative period after laparoscopic hysterectomy.
J Clin Anesth
2003
1.42
6
Stress response to hepatectomy in patients with a healthy or a diseased liver.
World J Surg
2003
1.10
7
Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
Hepatogastroenterology
2005
0.98
8
Liver resection for benign liver tumors: indications and outcome.
Am J Surg
2007
0.96
9
Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation.
Eur J Clin Invest
2011
0.96
10
Intraoperative blood loss is a risk factor for complications in donors after living donor hepatectomy.
Liver Transpl
2006
0.95
11
Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantation.
Ann Transplant
2010
0.95
12
Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation.
Clin Transplant
2010
0.95
13
Routine microsurgical biliary reconstruction decreases early anastomotic complications in living donor liver transplantation.
Liver Transpl
2009
0.95
14
Evaluation of living liver donors.
Transplantation
2003
0.95
15
Right lobe living donor liver transplantation-addressing the middle hepatic vein controversy.
Ann Surg
2003
0.94
16
Intrathecal administration of roscovitine inhibits Cdk5 activity and attenuates formalin-induced nociceptive response in rats.
Acta Pharmacol Sin
2005
0.92
17
Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan.
Transplantation
2008
0.91
18
Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
Clin Transplant
2002
0.91
19
The renal-sparing efficacy of basiliximab in adult living donor liver transplantation.
Liver Transpl
2005
0.90
20
Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation.
Acta Pharmacol Sin
2006
0.90
21
Improving hepatic and portal venous flows using tissue expander and Foley catheter in liver transplantation.
Clin Transplant
2006
0.90
22
Acute coronary syndrome in cisatracurium-induced anaphylactic shock: Kounis syndrome.
Acta Anaesthesiol Taiwan
2008
0.89
23
Western blotting analysis for quantitative detection of CYP2C19 expression in liver tissues in the setting of living donor liver transplantation.
Hepatogastroenterology
2012
0.89
24
Experimental and clinical significance of antinuclear antibodies in liver transplantation.
Transplantation
2007
0.88
25
Single injection of naked plasmid encoding alpha-melanocyte-stimulating hormone protects against thioacetamide-induced acute liver failure in mice.
Biochem Biophys Res Commun
2004
0.88
26
Impact of vaccine therapy using nuclear histone H1 on allograft survival in experimental organ transplantation.
Transpl Immunol
2007
0.86
27
Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice.
Biochem Biophys Res Commun
2005
0.85
28
Involvement of autoimmunity against nuclear histone H1 in liver transplantation tolerance.
Transpl Immunol
2008
0.85
29
The effects of anti-histone H1 antibody on immune cells responsible for rejection reaction.
Mol Immunol
2005
0.85
30
Multislice computed tomography angiography in pediatric liver transplantation.
Transplantation
2003
0.84
31
Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
J Hepatol
2009
0.83
32
Preemptive analgesia installation during gynecologic laparoscopy: a randomized trial.
J Minim Invasive Gynecol
2005
0.83
33
Protective effect of MDL28170 against thioacetamide-induced acute liver failure in mice.
J Biomed Sci
2004
0.83
34
Long-term results of living donor liver transplantation for glycogen storage disorders in children.
Liver Transpl
2007
0.82
35
Diarrhea in medical care workers with severe acute respiratory syndrome.
J Clin Gastroenterol
2004
0.82
36
Major hepatectomy in children: approaching blood transfusion-free.
World J Surg
2006
0.81
37
Living donor liver transplantation for biliary atresia.
Chang Gung Med J
2007
0.80
38
Alpha-melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice.
J Gene Med
2006
0.80
39
Donor graft outflow venoplasty in living donor liver transplantation.
Liver Transpl
2006
0.79
40
Section 1. Image evaluation of fatty liver in living donor liver transplantation.
Transplantation
2014
0.79
41
Maintenance of normothermia at operation room temperature of 24 degrees C in adult and pediatric patients undergoing liver transplantation.
Transpl Int
2005
0.79
42
Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation.
World J Gastroenterol
2005
0.79
43
Intra-operative management of low portal vein flow in pediatric living donor liver transplantation.
Transpl Int
2012
0.78
44
Anesthetic management of a patient with Alagille's syndrome undergoing living donor liver transplantation without blood transfusion.
Chang Gung Med J
2004
0.78
45
Hepatic pseudotumor in long-standing biliary atresia patients undergoing liver transplantation.
Liver Transpl
2007
0.78
46
Risk factors for intraoperative portal vein thrombosis in pediatric living donor liver transplantation.
Clin Transplant
2004
0.78
47
Perforation of the right ventricle by a pulmonary artery catheter that continues to measure cardiac output and mixed venous saturation.
J Clin Anesth
2005
0.78
48
Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.
J Gastroenterol Hepatol
2007
0.78
49
Predictive factors for pediatric patients requiring massive blood transfusion during living donor liver transplantation.
Ann Transplant
2013
0.78
50
High concentration of magnolol induces hepatotoxicity under serum-reduced conditions.
Phytomedicine
2009
0.77
51
Section 18. Professional framework for liver transplantation for overseas patients: traveling for living donor liver transplantation.
Transplantation
2014
0.77
52
Outcomes of long storage times for cryopreserved vascular grafts in outflow reconstruction in living donor liver transplantation.
Liver Transpl
2014
0.77
53
Solitary pulmonary nodule in the liver transplant candidate: importance of diagnosis and treatment.
Liver Transpl
2010
0.77
54
3DCT angiography for detection of vascular complications in pediatric liver transplantation.
Liver Transpl
2004
0.76
55
The immunological role of lipid transfer/metabolic proteins in liver transplantation tolerance.
Transpl Immunol
2006
0.76
56
Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressants.
Transpl Immunol
2006
0.76
57
The method and accuracy of documentation of intraoperative fluids management in liver transplantation recipients.
Ann Transplant
2011
0.76
58
Deceased-donor liver transplantation: 10 years' experience at Change Gung Memorial Hospital-Kaohsiung Medical Center.
Chang Gung Med J
2005
0.76
59
Dextrose in the banked blood products does not seem to affect the blood glucose levels in patients undergoing liver transplantation.
World J Gastroenterol
2005
0.75
60
Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release.
Cytokine
2009
0.75
61
Predictive factors associated with re-exploration for hemostasis in living donor liver transplantation.
Ann Transplant
2012
0.75
62
Atrial septal defect in end-stage liver disease children before and after liver transplantation.
Surgery
2007
0.75
63
Systemic immune response after laparoscopic and open cholecystectomy.
World J Surg
2002
0.75
64
Angioplasty treatment of hepatic vein stenosis in pediatric liver transplants: long-term results.
Transpl Int
2005
0.75
65
Use of a refined operative strategy in combination with the multidisciplinary approach to manage blunt juxtahepatic venous injuries.
J Trauma
2005
0.75
66
Intraoperative blood and fluid administration differences in primary liver transplantation versus liver retransplantation.
Acta Anaesthesiol Taiwan
2011
0.75
67
Modified protective suits for anesthesiologists performing tracheal intubation for severe acute respiratory syndrome patients in Taiwan.
Anesthesiology
2004
0.75
68
Living donor liver transplantation in children with congenital heart disease.
Transplantation
2007
0.75
69
Permanent loss of cervical spinal cord function after posterolateral fusion for lumbar spinal pyogenic spondylitis.
Orthopedics
2008
0.75
70
Heat preconditioning ameliorates hepatocyte viability after cold preservation and rewarming, and modulates its immunoactivity.
Transpl Immunol
2007
0.75
71
Section 8. Management of portal venous complications in pediatric living donor liver transplantation.
Transplantation
2014
0.75
72
Two cases of massive pleural effusion noted only after induction of anesthesia in living donor liver transplantation.
J Anesth
2011
0.75
73
The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells.
Transpl Immunol
2007
0.75
74
Atropine-triggered idiopathic ventricular tachycardia in an asymptomatic pediatric patient.
Can J Anaesth
2004
0.75